HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[By-pass operations in obstructions of the aorto-iliac axis].

Abstract
The A. report their own experience about 226 cases of by-pass and 46 cases of T.E.A. for aorto-iliac disease performed by the Department of Surgical Semeiotics in the University of Trieste. The results of 116 direct bilateral implants and of 23 monolateral implants are discussed. Intraoperatory mortality was about 8%. Early complications occurred in 9, 4%: thrombosis and prosthesis infections (5 cases) were the most important accidents. Late complications were thrombosis (19 cases), infection (1 case) and 2 A-E fistulas. It is possible to obviate late thrombosis with early reoperations. Long-term follow-up (106 patients) shows good results in 70, 8%, while thrombosis of the by-pass occurred in 17, 9%; 12 patients showed a distal ischemia of the limbs and required complementary reoperations. On the basis of their experience the A. stress that the results of aorto-femoral by-pass should be considered quite satisfactory.
AuthorsP Pietri, G Alagni, R Domeniconi, R Adovasio, F Gabrielli
JournalMinerva chirurgica (Minerva Chir) 1980 Dec 15-31 Vol. 35 Issue 23-24 Pg. 1863-8 ISSN: 0026-4733 [Print] Italy
Vernacular TitleGli interventi di by-pass nelle ostruzioni dell'asse aorto-iliaco.
PMID6457256 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Polyethylene Terephthalates
Topics
  • Aortic Diseases (surgery)
  • Arterial Occlusive Diseases (surgery)
  • Bacterial Infections
  • Blood Vessel Prosthesis
  • Humans
  • Iliac Artery
  • Ischemia (etiology)
  • Polyethylene Terephthalates
  • Postoperative Complications
  • Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: